期刊文献+

血浆内皮素和一氧化氮与肾性高血压及肾机能的关系 被引量:2

Study on the relationship between plasma endothelin nitric oxide concentration and renal hypertension and renal function
下载PDF
导出
摘要 采用放射免疫及生化方法测定60 例肾脏病患者血浆 E T 和 N O 浓度,并进行相关分析。结果示:①肾脏病组血浆 E T1 浓度高于正常对照组( P < 0 .01) ;血浆 N O 浓度低于正常对照组( P < 0 .01) 。②高血压组患者血浆 E T 高于非高血压组( P < 0 .01) ,血浆 N O 低于非高血压组( P < 0 .01) 。③肾机能不全组血浆 E T 高于肾机能正常组( P < 0 .01) ,血浆 N O 低于肾机能正常组( P < 0 .05) 。④ E T 分别与血压、 B U N 及 Scr 呈正相关, N O 分别与血压、 B U N 及 Scr 呈负相关。提示血浆 E T 及 N O 可能参与肾性高血压的病理生理过程。 To investigate the relationship between plasma endothelin(ET), nitric oxide(NO) levels and, renal hypertension and renal function. Methods: The plasma concentration of ET 1 was detected by immunofluorescence assay. The plasma concentration of NO was detected by biochemistry assay. Results: ① In renal disease patients, plasma concentration ET 1 was markedly elevated, and plasma concentration of NO was decreased, compared with the healthy subjects(P<0.01). ② Plasma concentration of ET 1 was markedly increased and plasma concentration of NO was decreased in the patients with renal hypertension. ③ Plasma level of ET 1 was higher, and plasma level of NO was lower in the patients with renal function damage than that of those without renal function damage. ④ BP, BUN and Scr were positively correlated with plasma ET 1, but they were negatively correlated with plasma concentration of NO. Conclusion: Plasma ET 1 and NO may play an important role in pathogenesis of renal hypertention; the change of their levels may be related to the progress of these renal diseases.
出处 《湖南医科大学学报》 CSCD 1999年第4期381-383,共3页 Bulletin of Hunan Medical University
关键词 内皮素 一氧化氮 肾功能试验 肾性高血压 endothelin nitric oxide hypertension,renal kidney function test
  • 相关文献

参考文献6

二级参考文献1

  • 1戴勇,肾脏病与透析肾移植杂志,1994年,3卷,285页

共引文献29

同被引文献14

  • 1[2] King AJ, Brener BM, Anderson S. Endothelin: apotent tenal and syst emic vasoconstrictor peptide[J]. Am J Physiol, 1990,256:F1051-1057.
  • 2[3] Schichiri M, Hirata Y, Ando K, et al. Plasma endothelin levels in hypertension and chronic renal failure[J]. Hypertension, 1990,15:493-499.[ ZK)]
  • 3[5] Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass[J]. J Cl in Invest, 1985,76:612-619.
  • 4[6] Zatz R, Dunn BR, Meyer TW, et al. Prevention of diabetic glome rulopathy by pharmacological amelioration of glomerular capillary hypertension[ J]. J Clin Invest, 1986,77:1975-1930.
  • 5[7] Morelli E, Loon N, Meyer TW, et al. Effects of converting-enz yme inhibition on barrier function in diabetic glomerulopathy[J]. Diabetes, 19 90,39:76-82.
  • 6[8] Remuzzi A, Puntorieri, S Battaglia C, et al. Angiothensin conv erting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat[J]. J Clin Invest, 1990,85:54 1-549.
  • 7[9] Lin YH, Yang XP, Sharow VG, et al. Paracrine systems in the ca rdioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion in jury in rats[J]. Hypertension, 1996,27:7-13.
  • 8Celermajer DS,Sorensen KE,Gooch VM,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340(8828):1111-1115.
  • 9Corretti MC,Anderson TJ,Benjamin E J,et al.Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery:a report of the International Brachial Artery Reactivity Task Forcey[J].J Am Coll Cardiol,2002,39(2):257-265.
  • 10Katafuchi R,Kiyoshi Y,Oh Y,et al.Glomerular score as a prognosticator in IgA nephropathy:its usefulness and limitation[J].Clin Nephrol,1998,49(1):1-8.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部